The Susan G. Komen for the Cure Foundation is facing a fight to keep controversy from undermining its fundraising efforts.
After announcing that it would withdraw funding from Planned Parenthood screening programs last week — and then reversing that decision three days later — the foundation now faces the challenging task of repairing its image and trying to lure back disillusioned donors.
One of the nation's largest breast cancer charities, the foundation spends tens of millions of dollars annually on breast cancer research, education and screening.
When Lisa Rentz decided she'd had enough of birth control pills, she walked into her local drug store and picked up something different: a vaginal contraceptive film that contains the spermicide nonoxynol-9, or n-9.
StateImpact Idaho's Molly Messick reports on two people coping with the lingering effects of an economic downturn.
Before the recession, Idaho had one of the fastest growing economies in the country. But last year, its jobless rate peaked at nearly 10 percent. That number has begun to creep downward – but many workers in the state are still struggling to replace the jobs they've lost.
Yale University student Marina Keegan received an email last May from Bridgewater Associates, one of the world's largest hedge funds, offering her $100 if she said why she didn't apply for a summer internship.
Keegan, an English major, decided to take Bridgewater up on its offer.
"It was only sort of once I was inside the room when I realized ... maybe I'm helping them perfect their recruiting machine, which is exactly what we were doing," Keegan tells weekends on All Things Considered host Guy Raz.
A half-century ago, autopsies — sometimes called the ultimate medical audit — were an integral part of American health care, performed on roughly half of all patients who died in hospitals. But today, autopsies are conducted on roughly 5 percent of such patients, and experts say that is a troubling trend.